The same product as STELARA®
Produced from the same cell line and at the same manufacturing sites as STELARA®
Priced lower than branded STELARA® by wholesale acquisition cost
Ustekinumab: A Treatment Option That Puts Patients First by Offering an Alternative for Patients to Stay on Their Current Therapy
References: 1. U.S. Food and Drug Administration. FAQs–Purple Book. Accessed October 11, 2024. https://purplebooksearch.fda.gov/faqs 2. Ustekinumab [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc. 3. STELARA® [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc. 4. AnalySource®. Accessed February 20, 2025. https://www.analysource.com/